European Services & Experience

While the European Union as a whole has always been very strong in the volume and efficiency of clinical trials conducted, the number of trials initiated in Central and Eastern Europe has more than tripled over the past 5 years, making the region a key part of global clinical research. Countries including Bulgaria, Czech Republic, Hungary, Poland, Romania, Russia, Turkey, and Ukraine are expected to witness considerable growth through 2012 because of low cost advantages and the ease with which they can recruit from an abundant heterogenous patient population.

While it is clear that many options exist globally to satisfy the growing demand for clinical trials, cost-effective opportunities may not be as attractive when weighed against regional expertise and regulatory conditions. That’s why it’s important to partner with the right CRO in Europe when conducting your global trial. We have the global expertise and local knowledge of clinical investigators, patient populations, regional regulatory nuances and cultural differences your trials require.

We are headquartered in Research Triangle Park, NC, USA, with European headquarters in Zurich, Switzerland with an additional office in Munich, Germany. Within these offices we deliver a full array of outsourced regulatory, strategic development, clinical development, and post-approval services.

 

 

  • Biostatistics
  • Clinical Monitoring
  • Data Management
  • GCP training
  • Global Study Feasibility
  • GxP/CMC Quality Assurance Consultancy
  • Legal Representation
  • Medical Affairs & Monitoring
  • Patient Recruitment
  • Pharmacovigilance & Safety surveillance
  • Project Management
  • Regulatory & Strategic Consultancy
  • Regulatory Submissions & Filings
  • Site Selection & Management
  • TEMPO eClinical Platform

 

 

  • Oncology: 19%
  • Infectious Diseases: 14%
  • Cardio/Metabolism: 12%
  • Central Nervous System: 9%
  • Gastroenterology: 9%
  • Nephrology/Renal: 5%
  • Pulmonary: 5%
  • Immunology: 5%
  • Eye and Ear: 3%
  • Rheumatology: 3%
  • Orthopedic: 3%
  • Other: 13%

 

 

  • Phase 1: 12%
  • Phase 2: 20%
  • Phase 3: 47%
  • Phase 4: 13%
  • Registry: 8%

 

Looking for help in Europe?

Let's Chat